Brett K Haumann's Net Worth
$11.2 Million
Who is Brett K Haumann?
Brett K Haumann has an estimated net worth of $11.2 Million. This is based on reported shares across multiple companies, which include Theravance Biopharma, Inc., and Aimmune Therapeutics, Inc..
SEC CIK
Brett K Haumann's CIK is 0001607733
Past Insider Trading and Trends
2020 was Brett K Haumann's most active year for acquiring shares with 4 total transactions. Brett K Haumann's most active month to acquire stocks was the month of January. 2020 was Brett K Haumann's most active year for disposing of shares, totalling 8 transactions. Brett K Haumann's most active month to dispose stocks was the month of July. 2015 saw Brett K Haumann paying a total of $0.00 for 135,000 shares, this is the most they've acquired in one year. In 2020 Brett K Haumann cashed out on 117,121 shares for a total of $2,722,059.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01
Chief Medical OfficerBrett K Haumann owns 242,499 units of Ordinary Shares which is worth $1,942,416.99 and 247,161 units of Ordinay Shares which is worth $1,979,759.61. In the year 2014 Brett K Haumann filed a total of 33 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.82% | -35.67K |
$18.79 | -$670,276.88 | 242.5K |
Feb 20
| |||
Form 4
| -1.64% | -4.64K |
$17.21 | -$79,837.19 | 278.17K |
Nov 20
| |||
Form 4
| -9.49% | -29.65K |
$18.28 | -$541,890.12 | 282.81K |
Aug 20 - Aug 21
| |||
Form 4
| -1.33% | -4.21K |
$26.67 | -$112,334.04 | 312.46K |
May 20
| |||
Form 4
| -9.59% | -33.61K |
$25.90 | -$870,447.20 | 316.67K |
Feb 20
| |||
Form 4
| +51.45% | 119K |
—
|
—
| 350.28K |
Feb 3
| |||
Form 4
| -1.15% | -2.69K |
$17.60 | -$47,379.20 | 231.28K |
Nov 20
| |||
Form 4
| -1.15% | -2.71K |
$21.51 | -$58,292.10 | 233.97K |
Aug 20
| |||
Form 4
| -1.13% | -2.71K |
$19.84 | -$53,667.20 | 236.68K |
May 20
| |||
Form 4
| -3.15% | -7.78K |
$27.00 | -$210,006.00 | 239.38K |
Feb 20
| |||
Form 4
| +33.53% | 112.25K |
—
|
—
| 447.07K |
Feb 5
| |||
Form 4
| -5.18% | -7.37K |
$24.79 | -$182,652.72 | 134.91K |
Nov 20
| |||
Form 4
| -4.49% | -6.68K |
$26.95 | -$180,106.85 | 142.28K |
Aug 20
| |||
Form 4
| -15.34% | -26.99K |
$24.31 | -$656,151.21 | 148.96K |
May 20
| |||
Form 4
| +23.73% | 33.75K |
—
|
—
| 175.95K |
May 14
| |||
Form 4
| -5.51% | -8.29K |
$29.09 | -$241,243.37 | 142.2K |
Feb 20
| |||
Form 4
| +6.36% | 9K |
—
|
—
| 150.5K |
Feb 12
| |||
Form 4
| -5.25% | -7.85K |
$28.58 | -$224,238.68 | 141.5K |
Nov 20
| |||
Form 4
| -4.52% | -7.06K |
$27.40 | -$193,553.60 | 149.34K |
Aug 20
| |||
Form 4
| -4.32% | -7.07K |
$36.83 | -$260,203.95 | 156.41K |
May 20
| |||
Form 4
| -7.89% | -14.00K |
$31.50 | -$440,974.72 | 163.47K |
Mar 6 - Mar 7
| |||
Form 4
| -7.52% | -14.43K |
$33.78 | -$487,580.52 | 177.47K |
Feb 20
| |||
Form 4
| +4.92% | 9K |
—
|
—
| 191.91K |
Feb 6
| |||
Form 4
| -2.86% | -5.39K |
$31.96 | -$172,200.48 | 182.91K |
Nov 20
| |||
Form 4
| -2.33% | -4.49K |
$27.99 | -$125,703.09 | 188.29K |
Aug 25
| |||
Form 4
| -6.82% | -14.12K |
$27.94 | -$394,455.96 | 192.78K |
Aug 19 - Aug 20
| |||
Form 4
| -2.18% | -4.61K |
$20.55 | -$94,694.40 | 206.9K |
May 20
| |||
Form 4
| +74.07% | 90K |
—
|
—
| 211.51K |
Mar 15
| |||
Form 4
| -13.17% | -18.43K |
$15.65 | -$288,351.25 | 121.51K |
Feb 20
| |||
Form 4
| -0.56% | -781.00 |
$17.17 | -$13,409.77 | 139.93K |
Nov 20
| |||
Form 4
| +2,362.62% | 135K |
—
|
—
| 140.71K |
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aimmune Therapeutics, Inc. No price found
InvestorBrett K Haumann used to own units in Common Stock, $0.0001 par value but no longer holds any shares there.acquired a total of 13,313 shares in Aimmune Therapeutics, Inc., Brett also disposed a total of 19,563 shares of Aimmune Therapeutics, Inc. equalling to $674,923.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -19.56K |
$34.50 | -$674,923.50 |
0
|
Oct 10 - Oct 13
| |||
Form 4
| +213.01% | 13.31K |
—
|
—
| 19.56K |
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||